Seres Therapeutics
NASDAQ: MCRB
Healthcare
Biotechnology
Rank
#27172
Market Cap
61.51 M
Volume
131,038
Price
7.06
Change (%)
1.36%
Country or region
United States
United States
Seres Therapeutics Stock Split History Overview
This company has undergone a total of one stock splits throughout its history. One reverse splits occurred, consolidating shares and stabilizing stock prices. The most recent split occurred on April 22, 2025 with a ratio of 1-for-20. These adjustments reflect the company's strategic efforts to align stock performance with market conditions.
Seres Therapeutics (NASDAQ: MCRB) Stock Split History
| Date | Split Ratio | Multiple | Cumulative multiple | Type |
|---|---|---|---|---|
| April 22, 2025 | 1:20 | x0.05 | x0.05 | Reverse |
Frequently Asked Questions
If Seres Therapeutics (stock symbol: NASDAQ: MCRB) had never undergone any stock splits, its price per share today would be approximately 0.35 USD. This calculation reflects the cumulative effect of all splits, including the most recent split (ratio: 1-for-20) that occurred on April 22, 2025.
Seres Therapeutics (stock symbol: NASDAQ: MCRB) has undergone a total of one stock splits. The most recent split occurred on April 22, 2025. One share bought prior to the first split on April 22, 2025 would now equal 0.05 shares.
Seres Therapeutics (stock symbol: NASDAQ: MCRB) has undergone one stock splits in its history. The most recent split, a 1-for-20 split, occurred on April 22, 2025. While future splits are not guaranteed, significant increases in stock price could prompt consideration for another split.
